Skip to main content
Download PDF

Child transmission of SARS-CoV-2: a systematic review and meta-analysis

BMC Pediatrics volume 22, Article number: 172 (2022) Cite this article

Abstract

Background

Understanding of the role of children in COVID-19 transmission has significant implications for school and childcare policies, as well as appropriate targeting of vaccine campaigns. The objective of this systematic review was to identify the role of children in SARS-CoV-2 transmission to other children and adults.

Methods

MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, and Web of Science were electronically searched for articles published before March 31, 2021. Studies of child-to-child and child-to-adult transmission and quantified the incidence of index and resulting secondary attack rates of children and adults in schools, households, and other congregate pediatric settings were identified. All articles describing confirmed transmission of SARS-CoV-2 from a child were included. PRISMA guidelines for data abstraction were followed, with each step conducted by two reviewers.

Results

40 of 6110 articles identified met inclusion criteria. Overall, there were 0.8 secondary cases per primary index case, with a secondary attack rate of 8.4% among known contacts. The secondary attack rate was 26.4% among adult contacts versus 5.7% amongst child contacts. The pooled estimate of a contact of a pediatric index case being infected as secondary case was 0.10 (95% CI 0.03-0.25).

Conclusions

Children transmit COVID-19 at a lower rate to children than to adults. Household adults are at highest risk of transmission from an infected child, more so than adults or children in other settings.

Peer Review reports

Background

The SARS-CoV-2 pandemic has led to worldwide economic disruption, as well as the mass-closing of social programs, daycare, and childcare institutions. Nearly 90% of students worldwide had their education disrupted by mid-April 2020 due to school closures [1]. To date, the data to support ongoing school closures to prevent increases in community SARS-CoV-2 transmission remain unclear. Some modeling studies have reported limited reduction in overall mortality rates of only 2-4% from school closures [2]. There have been reports of large-scale outbreaks associated with school openings [3], but this finding has not been consistently demonstrated in similar settings [4, 5]. In this context, it is critical to understand the role of children in transmission of the SARS-CoV-2 virus.

There has been greater focus on COVID-19 infection in adults, where the vast majority of symptomatic cases and deaths have occurred [1]. Adults are often index cases in household clusters due to their higher number of social contacts, and many studies focus on adult index cases in households. The prevalence of COVID-19 is much lower in children, as the incidence is consistently less than half that of adult cases [6, 7] In addition, children often present with asymptomatic or mildly symptomatic infection, and thus may be underrepresented in much of the literature [7, 8] There have been several studies synthesizing the state of current knowledge around pediatric presentation with COVID-19 or transmission to children from family members, but comparatively few studies that surround the transmissibility of pediatric infection [2, 9, 10] Those that have evaluate transmissibility systematically have largely done so early in the pandemic during maximal lockdowns and before many schools re-opened. This information can play an important role in decisions regarding reopening schools and the protective measures required in the classroom.

In this systematic review, we analyzed intra-familial and institutional spread of COVID-19 from a pediatric index case with confirmed child-to-adult or child-to-child infection. Our primary outcomes of interest were the secondary attack rates (SARs) of pediatric index cases in child and adult populations. We limited this review to contact-tracing studies with confirmed documented transmission to best characterize SARs.

Methods

Search strategy

For this systematic review and meta-analysis, we searched the literature to identify all published articles that reported evidence of SARS-CoV-2 transmission from children, either to other children or to adults. This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guideline for meta-analyses (Supplementary Methods 1). We developed a search strategy to identify evidence in the literature of pediatric SARS-CoV-2 transmission and refined its parameters in consultation with a research librarian. We searched Ovid MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Clinical Trials, and Web of Science databases for published studies in English exploring case-based pediatric COVID-19 transmission, published between January 1, 2020 to March 31, 2021 (Ovid MEDLINE search in Supplementary Methods 2).

Inclusion/exclusion criteria

We included published articles in English that demonstrated likely or confirmed transmission of SARS-CoV-2 from a child to an adult and/or to another child, with children defined as 18 years of age or younger. Likely transmission was defined as probable, symptomatic cases without a confirmed nucleic acid test by polymerase chain reaction (PCR). Confirmed transmission was defined as secondary cases confirmed by PCR via nasopharyngeal or salivary sample or through local community testing practices. We excluded articles that only demonstrated adult-to-child transmission or that did not contain information regarding the transmission of SARS-CoV-2. We excluded articles commenting on (1) neonatal (<28 days old) occurrences of transmission, (2) antibody results rather than PCR confirmed SARS-CoV-2, and (3) transmission occurring in a hospital setting. Letters, editorials, pre-printed articles, and review articles containing no primary data were excluded. Inclusion and exclusion criteria were specified in advance and documented in the study protocol.

Data extraction

After eliminating duplicates, two reviewers (two of S.L.S., B.Y.Z., C.B., or S.N.J.L.) independently screened all titles and abstracts to identify potentially eligible studies (Fig. 1). Full-text studies were then reviewed by two authors for eligibility (two of S.L.S., B.Y.Z., C.B., or S.N.J.L.). Disagreements were resolved by group discussion and review by a third reviewer (one of S.L.S., B.Y.Z., C.B., or S.N.J.L.). Articles found to be possibly eligible were fully assessed against inclusion and exclusion criteria by two reviewers independently (two of S.L.S., B.Y.Z., C.B., or S.N.J.L.). We also hand searched cited references in all potentially eligible studies for additional studies and identified additional studies cited in relevant review articles.

Fig. 1
figure 1

PRIMSA flow diagram

Full size image

The following data categories were collected when available: study design, country, patient demographics (age, sex, ethnicity), index case, transmission setting, and the number of exposed adults and children who were infected or uninfected.

Statistical analysis

Secondary attack rates were defined as the proportion of confirmed infections among all contacts when the number of total contacts were known. Secondary cases were defined as the number of confirmed infections among all contacts when the total number of contacts was unspecified. Meta-analysis was performed to evaluate the difference between household and school transmission settings, as well as differences between child-to-child and child-to-adult transmission. Studies with counts less than 10 were excluded from the meta-analysis. Pooled odds ratios (ORs) or proportions and their 95% confidence intervals (CI) were calculated through a random effects model based on DerSimonian and Laird with 0.25 for continuity correction [11]. For comparison of transmission to child contacts versus adult contacts, analysis was done solely in the household (close contact) settings with OR as a measure of effect size. For each meta-analysis, heterogeneity across studies was evaluated using Cochrane’s Q test and the inconsistency index (I2). A Cochrane’s Q P-value <0.05 indicated significant heterogeneity and I2 with values above 50% suggested substantial heterogeneity [12]. Results are presented as forest plots with 95% CI. All statistical analyses were performed using RStudio, version 1.4.1106.

Risk of bias assessment

Using the NIH Quality Assessment Tool for Case-Control Studies, two reviewers independently (two of S.L.S., B.Y.Z., C.B., or S.N.J.L.) rated the quality of included studies.

Results

6110 studies were screened for eligibility; of those, 40 articles met the eligibility criteria and were included in qualitative and quantitative analysis (Table 1). No additional articles were added from review of references. The majority of studies identified cases solely using PCR, with 9 reporting additional serologies in some or all cases, one study using rapid tests in call cases, one study conducted viral cultures, and 4 conducting whole exome sequencing in some or all cases (Supplementary Table 1). Symptoms described amongst cases were in keeping with the relatively mild or asymptomatic infection described broadly in the literature (Supplementary Table 1).

Table 1 Characteristics of included studies
Full size table

Of the 40 articles included, 13 studies were conducted in the North America [13,14,15,16,17,18,19,20,21,22,23,24,25], 14 in Europe [4, 10, 26,27,28,29,30,31,32,33,34,35,36,37], 12 from Asia [38,39,40,41,42,43,44,45,46,47,48,49], and 1 from Australia [50]. Of the 40 articles, 23 identified household child-to-adult or child-to-child transmission [10, 13,14,15, 18, 19, 24,25,26,27, 29, 32,33,34, 38,39,40,41,42, 45,46,47,48]. Seventeen articles documented transmission at a school [4, 17,18,19,20,21,22,23, 28,29,30, 35,36,37, 43, 44, 50], 6 in a childcare setting, [19, 28, 29, 31, 49, 50] and 5 from other social gatherings [16, 17, 23, 24, 47] (Table 1). Studies evaluating transmission in school and daycare settings, as well as structured social gatherings such as extracurricular sports, document a variety of non-pharmacological interventions to limit viral spread, including mask wearing, physical distancing, and maintenance of limited group sizes without intermingling (Supplementary Table 1).

A total of 457 pediatric index cases were included amongst all settings, resulting in a total of 355 secondary infections, of which 149 were pediatric cases and 206 were adult cases (Table 2). Overall, there was a mean of 0.78 secondary cases per index case (Table 2).

Table 2 Secondary Case Rate by Study Setting
Full size table

In studies that documented the total contacts exposed, the child-to-child transmission rate was 5.7% while the child-to-adult transmission rate was 26.4%. Overall, in studies that documented the total contacts exposed, 8.4% of contacts exposed to a confirmed pediatric index case were infected. We undertook a meta-analysis of overall pooled SARs, with data included from 13 studies [4, 14,15,16,17, 19, 24, 26, 31, 43, 47, 49, 50]. The pooled estimate for all studies with full contact tracing of a contact of a pediatric index case being infected as secondary case was 0.10 (95% CI 0.03-0.25), with high heterogeneity (I2 = 88%) (Fig. 2).

Fig. 2
figure 2

A Pooled estimates of secondary attack rate amongst child and adult contacts of pediatric index cases. B Pooled estimates of secondary attack rate amongst child versus adult contacts of pediatric index cases

Full size image

We undertook a meta-analysis of pooled SARs in close contact settings to compare transmission to children and to adults, with data included from 5 studies [14, 15, 24, 26, 47]. The pooled OR estimate for adults was 0.21 (95% CI 0.05-0.91), with no heterogeneity (I2 = 0%) (Fig. 2B).

Transmission Setting

There were 142 index patients documented in a school setting, with an overall mean of 0.83 secondary cases per index case (Table 3). In studies that documented the total contacts exposed, the child-to-child transmission rate in school settings was 2.0% of all child contacts, while the child-to-adult transmission rate in school settings was 11.7% (Table 3). Of all confirmed child-to-child transmission in school and childcare settings, almost half (48%) took place in secondary school environments.

Table 3 Secondary Attack Rate by Setting
Full size table

There were 314 index patients documented in a household setting, with an overall mean of 0.78 secondary cases per index case (Table 2). In studies that documented the total contacts exposed, the child-to-child transmission rate in household settings was 50.3% of all child contacts (Table 3). In studies that documented the total contacts exposed, the child-to-adult transmission rate in household settings was 47.0% of all adult contacts (Table 3).

We undertook a meta-analysis of pooled SARs in household and school settings [4, 14,15,16,17, 19, 24, 26, 31, 43, 47, 49, 50]. The SAR estimate for household settings was 0.18 (95% CI 0.07-0.42), with significant heterogeneity (I2 = 83%), while the SAR estimate for school settings was 0.04 (95% CI 0.00-0.28) with significant heterogeneity (I2 = 91%) (Fig. 3). Comparisons of these pooled SARs by setting were insufficiently powered to run.

Fig. 3
figure 3

Pooled estimates of SAR amongst contacts of pediatric index cases in household and school settings

Full size image

Country of origin

Amongst European and North American studies, there was a mean of 0.98 and 0.84 secondary cases per index case respectively, while amongst Asian studies there was an overall lower rate of 0.30 secondary cases per index case (Table 4). In studies that documented the total contacts exposed, in North America, Europe, and Asia, the child-to-child transmission rate was 4.2%, 9.9%, and 4.4% while the child-to-adult transmission rate was 17.8%, 37.4%, and 21.4% respectively (Table 5).

Table 4 Secondary case rate by continent
Full size table
Table 5 Secondary attack rates by continent
Full size table

Risk of bias assessment

Ten were deemed to be of good quality and have low risk of bias, while 22 were of fair quality and 8 were of poor quality (Supplementary Table 2). Studies deemed to be good quality all had clear study objectives, well-defined population groups, and consistently recruited from a single or homogeneous population. These studies had predefined exposure and outcome measures and defined timelines from exposure to outcome. Majority of these studies also had longitudinal follow-up to ensure delayed outcomes were adequately reported. Studies deemed to be fair or poor did not comment on potential confounding variables. Additionally, no studies reported the potential of multiple exposures or calculation of appropriate sample size.

Discussion

To our knowledge, this is the most comprehensive systematic review of cases of pediatric COVID-19 transmission in the literature and is the first to capture data beyond the first global pandemic wave. Our review suggests that overall, children have posed a relatively small risk of transmission, particularly to other children, with an average of less than one secondary case per index case. There was limited evidence of transmission in the school or childcare setting, echoing reports from other closely studied school populations [50,51,52]. Our findings challenge many of the current public health practices of closing or limiting full time care for children in daycares, schools, and extra-curricular programming, particularly as most studies included in this review reflected periods with schools open for in class learning.

Although our study demonstrates that children do not appear to be a major contributor to the spread of COVID-19, adolescents may still play a role. The ages of all index patients and contacts were not available for meta-analysis. Of the children confirmed to have become infected with COVID-19 at school, almost half (48%) of them were confirmed to have been adolescents in a secondary school environment. This is likely to be an under-estimate as not all ages were specified. Further, the most significant reported school outbreaks took place in secondary schools [23, 28, 36]. Continuing extensive school closures in the setting of adult vaccinations and in the absence of an ongoing community outbreak, is unnecessary. Studies have increasingly shown such closures to be harmful to children, as the mental health effects and the additional unintended consequences to the most vulnerable children are coming to light [53,54,55]. As an increasing proportion of adults are vaccinated in populations, we must continue to monitor the role of children in COVID-19 disease burden and transmission because the role of children may change in the face of an increasingly immune adult population. This will enable evidence-based decisions on vaccination of children to be made, in light of anticipated data from pediatric clinical trials of COVID-19 vaccines and other key issues such as equitable global distribution of COVID-19 vaccines.

Our study demonstrated that the core population at risk of COVID-19 infection from a child are those residing in the same household as the child, with a secondary attack rate of 47% to adults and 50% of children in this setting. However, there have been numerous studies demonstrating that children are less likely to be the index case in households to begin with, and are less likely than other household members to be infected by a family member [56,57,58,59]. This may also be attributed to the more intimate caregiver roles that adults in the household may play compared to other siblings. Furthermore, while many public health policies recommend self-isolation within households when one individual is infected, this is usually unrealistic for children who rely on at least one caregiver for day-to-day needs. Alternatively, it is possible that the higher rate of transmission to adults in the household was a result of their biological vulnerability to the virus and population-wide increased rates of infection [60]. In studies that have sought to evaluate seroprevalence amongst household contacts, regardless of index case, there have been mixed findings, but overall children appear to have lower overall seropositivity than older household members [61,62,63]. This matches our findings of overall lower transmission to other children in the household compared to transmission to other household adults, and may again reflect differing susceptibility to the virus. While these studies and population-wide seroprevalence studies do not clearly demonstrate transmission risk and would therefore be unlikely to significantly change the interpretation of our review’s findings, their findings do correlate with the transmission dynamics we identified in this review.

There remains limited data available regarding the potential for pediatric COVID-19 transmission in larger pediatric group settings such as schools and summer camps. Only a few studies in these settings were included in our study, while other settings contained sufficient contact-tracing data to be fully included in this review [64, 65]. Our study demonstrates that if a child with COVID-19 does attend a congregate setting with other children, the relative risk to others is quite low. However, this does not preclude super-spreading events from occurring, particularly among adolescents. There have been reports of extensive and rapid transmission in settings with prolonged contact, even where some measures to mitigate introduction of infected participants into the setting [17]. The role of adults in these settings at assisting spread remains unclear, but necessary, as many reports from school and daycare settings report similar, if not higher, rates of spread from teachers themselves than from students [15, 66]. Close monitoring of congregate pediatric settings, particularly intimate ones such as summer camps, will be critical until mass vaccination is achieved.

Our review, completed through March 2021, represents transmission in the absence of vaccine pressure. Large-scale COVID-19 vaccination campaigns began after the timing of most studies included in the review. As well, most of the studies with available data took place prior to the widespread development of virus variants with different transmission data. The potential role of child-to-child transmission will likely become even more prominent as many countries are quickly achieving vaccination of significant proportions of their adult populations. Our study, which demonstrates low rates of child-to-child transmission, argues that in the context of widespread adult vaccination, re-opening of schools and other childcare settings will no longer be risky from a transmission standpoint and will be vital in face of the ongoing mental health and other widespread detriments of keeping such settings closed.

In this study, we were unable to exhaustively collect all evidence of children who were SARS-CoV-2 positive, and yet did not transmit the virus. These are the most reported pediatric cases of COVID-19 in the literature, particularly early in the epidemic when children had limited contacts outside of the home but could not be included as they provided no clear information regarding transmission. As a result, our review may over-report documented transmission from children. Additionally, due to the relatively mild or absent illness most children have with COVID-19, there is an unknown number of untested cases of SARS-CoV-2 amongst pediatric patients with unspecified transmission that we are unable to capture in this review. As a result, these asymptomatic scenarios may have caused us to under-estimate the true transmission rate. We sought to focus on symptomatic children who would be at highest risk of transmission to others, which may miss some transmission from asymptomatic cases. Like other contact tracing studies [56, 67], we were also unable to control for the possibility of a ‘common exposure’ where two individuals were infected by the same source at the same time, but only one of the two was identified as the index case. Furthermore, we were limited by the many reports of pediatric COVID-19 cases without contact tracing available, clarity on ages of all cases, and/or larger studies that report outbreak size in relation to a communal pediatric setting but did not undergo thorough contact tracing to document the nature of the spread. Reporting of secondary school cases was particularly limited by unspecified ages in multiple studies, likely leading to an under-representation of adolescent index cases in school settings. The bias introduced in this study, with studied individuals having potentially a more clearly defined exposure than those in population-wide studies, might therefore over-account for cases amongst close contacts. Lastly, as assessed by the NIH Quality Assessment Tool, the quality of included studies were mostly deemed fair. Specifically, domains that may affect the overall validity of our results come from the lack of reporting of potential multiple exposures and potential confounding variables. Consequently, without knowing other exposures or additional risk factors impacting transmissibility, our reported rates may have over-reported the true transmission rate. In summary, some factors lead to potential over-estimation of transmission compared to our findings, while others may contribute to potential under-estimation of transmission, but the relative contributions of these factors are difficult to ascertain.

Additionally, most studies did not report cycle threshold cut-off values for PCR testing for reporting positive results, limiting our interpretation of the infectious potential of studied cases amongst and between individual studies, although all studies followed national reporting guidelines in their individual jurisdictions. We also acknowledge that the transmission characteristics of new SARS-CoV-2 variants may differ. We did not identify studies that clearly reflected variants of concern circulating in the population at the time data was collected; a focus on the changing transmission dynamics, particularly in pediatric cases, will be critical for ongoing studies to monitor.

Conclusions

In addition to the previously reports of children having milder disease course and better prognosis than adults, children also appear to be less likely to transmit COVID-19 than their adult counterparts. Household transmission remains the most prominent source of child-to-adult and child-to-child transmission. Further research is required to better understand how child transmission of COVID-19 has been impacted by the reopening of schools and the advancement of vaccines, as well as introduction of new variants.

Availability of data and materials

All data generated or analysed during this study are included in this published article [and its supplementary information files].

Abbreviations

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

PCR:

polymerase chain reaction

OR:

odds ratio

CI:

confidence interval

SAR:

secondary attack rate

References

  1. Donohue JM, Miller E. COVID-19 and School Closures. JAMA. 2020;324(9):845–7.

    Article  CAS  PubMed  Google Scholar 

  2. Viner RM, Russell SJ, Croker H, Packer J, Ward J, Stansfield C, et al. School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review. The Lancet Child & Adolescent Health. 2020;4(5):397–404.

    Article  CAS  Google Scholar 

  3. Stein-Zamir C, Abramson N, Shoob H, Libal E, Bitan M, Cardash T, et al. A large COVID-19 outbreak in a high school 10 days after schools’ reopening, Israel, May 2020. Eurosurveillance. 2020;25(29):2001352.

    Article  PubMed Central  Google Scholar 

  4. Heavey L, Casey G, Kelly C, Kelly D, McDarby G. No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020. Eurosurveillance. 2020;25(21):2–5.

    Article  Google Scholar 

  5. Im Kampe EO, Lehfeld A-S, Buda S, Buchholz U, Haas W. Surveillance of COVID-19 school outbreaks, Germany, March to August 2020. Eurosurveillance. 2020;25(38):2001645.

    Google Scholar 

  6. Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396(10247):313–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Boehmer TK, DeVies J, Caruso E, van Santen KL, Tang S, Black CL, et al. Changing Age Distribution of the COVID-19 Pandemic - United States, May-August 2020. MMWR Morbidity and mortality weekly report. 2020;69(39):1404–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145(6):e20200702.

  9. Merckx J, Labrecque JA, Kaufman JS. Transmission of SARS-CoV-2 by children. Deutsches Aerzteblatt Online. 2020.

  10. Maltezou HC, Magaziotou I, Dedoukou X, Eleftheriou E, Raftopoulos V, Michos A, et al. Children and Adolescents With SARS-CoV-2 Infection Epidemiology, Clinical Course and Viral Loads. Pediatric Infectious Disease Journal. 2020;39(12):E388-E92.

    Article  Google Scholar 

  11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

  12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327(7414):557–60.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Pitman-Hunt C, Leja J, Jiwani ZM, Rondot D, Ang J, Kannikeswaran N. Severe Acute Respiratory Syndrome-Coronavirus-2 Transmission in an Urban Community: The Role of Children and Household Contacts. J Pediatric Infect Dis Soc. 2021;10(9):919–21.

  14. Laws RL, Chancey RJ, Rabold EM, Chu VT, Lewis NM, Fajans M, Reses HE, Duca LM, Dawson P, Conners EE, Gharpure R, Yin S, Buono S, Pomeroy M, Yousaf AR, Owusu D, Wadhwa A, Pevzner E, Battey KA, Njuguna H, Fields VL, Salvatore P, O'Hegarty M, Vuong J, Gregory CJ, Banks M, Rispens J, Dietrich E, Marcenac P, Matanock A, Pray I, Westergaard R, Dasu T, Bhattacharyya S, Christiansen A, Page L, Dunn A, Atkinson-Dunn R, Christensen K, Kiphibane T, Willardson S, Fox G, Ye D, Nabity SA, Binder A, Freeman BD, Lester S, Mills L, Thornburg N, Hall AJ, Fry AM, Tate JE, Tran CH, Kirking HL. Symptoms and Transmission of SARS-CoV-2 Among Children - Utah and Wisconsin, March-May 2020. Pediatrics. 2021;147(1):e2020027268.

  15. Lopez AS, Hill M, Antezano J, Vilven D, Rutner T, Bogdanow L, et al. Transmission Dynamics of COVID-19 Outbreaks Associated with Child Care Facilities - Salt Lake City, Utah, April-July 2020. MMWR-Morb Mortal Wkly Rep. 2020;69(37):1319–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Drezner JA, Drezner SM, Magner KN, Ayala JT. COVID-19 Surveillance in Youth Soccer During Small Group Training: A Safe Return to Sports Activity. Sports Health.3.

  17. Pray IW, Gibbons-Burgener SN, Rosenberg AZ, Cole D, Borenstein S, Bateman A, et al. COVID-19 Outbreak at an Overnight Summer School Retreat - Wisconsin, July-August 2020. MMWR Morbidity and mortality weekly report. 2020;69(43):1600–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gillespie DL, Meyers LA, Lachmann M, Redd SC, Zenilman JM. The Experience of 2 Independent Schools With In-Person Learning During the COVID‐19 Pandemic. Journal of School Health. 2021.

  19. Teherani MF, Kao CM, Camacho-Gonzalez A, Banskota S, Shane AL, Linam WM, et al. Burden of Illness in Households With Severe Acute Respiratory Syndrome Coronavirus 2–Infected Children. J Pediatr Infect Dis Soc. 2020;9(5):613–6.

    Article  Google Scholar 

  20. Gold JA. Clusters of SARS-CoV-2 infection among elementary school educators and students in one school district—Georgia, December 2020–January 2021. MMWR Morbidity and mortality weekly report. 2021;70.

  21. Hershow RB, Wu K, Lewis NM, Milne AT, Currie D, Smith AR, et al. Low SARS-CoV-2 Transmission in Elementary Schools—Salt Lake County, Utah, December 3, 2020–January 31, 2021. Morbidity and Mortality Weekly Report. 2021;70(12):442.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Dawson P, Worrell MC, Malone S, Tinker SC, Fritz S, Maricque B, et al. Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies—St. Louis County and City of Springfield, Missouri, December 2020. Morbidity and Mortality Weekly Report. 2021;70(12):449.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Siegel M, Kloppenburg B, Woerle S, Sjoblom S, Danyluk G. Notes from the Field: SARS-CoV-2 Transmission Associated with High School Football Team Members—Florida, September–October 2020. Morbidity and Mortality Weekly Report. 2021;70(11):402.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Schwartz NG, Moorman AC, Makaretz A, Chang KT, Chu VT, Szablewski CM, et al. Adolescent with COVID-19 as the Source of an Outbreak at a 3-Week Family Gathering—Four States, June–July 2020. Morbidity and Mortality Weekly Report. 2020;69(40):1457.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lewis NM, Duca LM, Marcenac P, Dietrich EA, Gregory CJ, Fields VL, et al. Characteristics and timing of initial virus shedding in severe acute respiratory syndrome coronavirus 2, Utah, USA. Emerg Infect Dis. 2021;27(2):352.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Posfay-Barbe KM, Wagner N, Gauthey M, Moussaoui D, Loevy N, Diana A, L'Huillier AG. COVID-19 in Children and the Dynamics of Infection in Families. Pediatrics. 2020;146(2):e20201576.

  27. Heudorf U, Steul K, Gottschalk R. Sars-Cov-2 in children - insights and conclusions from the mandatory reporting data in Frankfurt am Main, Germany, March-July 2020. Gms Hygiene and Infection Control. 2020;15:12.

    Google Scholar 

  28. Ehrhardt J, Ekinci A, Krehl H, Meincke M, Finci I, Klein J, et al. Transmission of SARS-CoV-2 in children aged 0 to 19 years in childcare facilities and schools after their reopening in May 2020, Baden-Württemberg, Germany. Eurosurveillance. 2020;25(36):2001587.

    Article  CAS  PubMed Central  Google Scholar 

  29. Ismail SA, Saliba V, Bernal JL, Ramsay ME, Ladhani SN. SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England. The Lancet Infectious Diseases. 2021;21(3):344–53.

    Article  CAS  PubMed  Google Scholar 

  30. Danis K, Epaulard O, Bénet T, Gaymard A, Campoy S, Botelho-Nevers E, et al. Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020. Clin Infect Dis. 2020;71(15):825–32.

    Article  CAS  PubMed  Google Scholar 

  31. Okarska-Napierala M, Mandziuk J, Kuchar E. SARS-CoV-2 Cluster in Nursery, Poland. Emerg Infect Dis. 2021;27(1):317–9.

    Article  CAS  PubMed Central  Google Scholar 

  32. Abbas M, Törnhage C-J. Family Transmission of COVID-19 Including a Child with MIS-C and Acute Pancreatitis. International medical case reports journal. 2021;14:55–65.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Soriano-Arandes A, Gatell A, Serrano P, Biosca M, Campillo F, Capdevila R, et al. Household SARS-CoV-2 transmission and children: a network prospective study. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America. 2021.

  34. Fiel-Ozores A, González-Durán ML, Novoa-Carballal R, Fernández-Pinilla I, Cabrera-Alvargonzález JJ, Martínez-Reglero C, et al. Differential clinic in children infected by SARS-CoV-2, traceability of contacts and cost-effectiveness of diagnostic tests: Cross-sectional observational study. Anales de Pediatría (English Edition). 2021.

  35. Jordan I, de Sevilla MF, Fumado V, Bassat Q, Bonet-Carne E, Fortuny C, et al. Transmission of SARS-CoV-2 infection among children in summer schools applying stringent control measures in Barcelona, Spain. Clinical Infectious Diseases. 2021.

  36. Buonsenso D, Graglia B. High rates of SARS-CoV‐2 transmission in a high‐school class. Journal of Paediatrics and Child Health. 2021;57(2):299.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Brandal LT, Ofitserova TS, Meijerink H, Rykkvin R, Lund HM, Hungnes O, et al. Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020. Eurosurveillance. 2021;26(1):2–7.

    Article  Google Scholar 

  38. Lin G-t, Zhang Y-h, Xiao M-f, Wei Y, Chen J-n, Lin D-j, et al. Epidemiological investigation of a COVID-19 family cluster outbreak transmitted by a 3-month-old infant. Health Information Science and Systems. 2021;9(1):1–10.

    Article  Google Scholar 

  39. Ji T, Chen HL, Xu J, Wu LN, Li JJ, Chen K, et al. Lockdown Contained the Spread of 2019 Novel Coronavirus Disease in Huangshi City, China: Early Epidemiological Findings. Clinical Infectious Diseases. 2020;71(6):1454–60.

    Article  CAS  PubMed  Google Scholar 

  40. Lin J, Duan J, Tan T, Fu Z, Dai J. The isolation period should be longer: Lesson from a child infected with SARS-CoV-2 in Chongqing, China. Pediatr Pulmonol. 2020;55(6):E6-E9.

    Article  PubMed  Google Scholar 

  41. Fong M, Cowling B, Leung G, Wu P. Letter to the editor: COVID-19 cases among school-aged children and school-based measures in Hong Kong, July 2020. Eurosurveillance. 2020;25(37):2001671.

    Article  PubMed Central  Google Scholar 

  42. Cesilia C, Sudarmaji S, Setiabudi D, Nataprawira HM. Case report of a COVID-19 family cluster originating from a boarding school. Paediatrica Indonesiana. 2021;61(1):49–55.

    Article  Google Scholar 

  43. Yung CF, Kam KQ, Nadua KD, Chong CY, Tan NWH, Li J, Lee KP, Chan YH, Thoon KC, Ng KC. Novel coronavirus 2019 transmission risk in educational settings. Clin Infect Dis. 2021;72(6):1055–8.

  44. Wong J, Jamaludin SA, Alikhan MF, Chaw L. Asymptomatic transmission of SARS-CoV‐2 and implications for mass gatherings. Influenza Other Respir Viruses. 2020.

  45. Gharekhanloo F, Sedighi I, Khazaei S. Variety of radiological findings in a family with COVID-19: a case report. Egypt J Radiol Nucl Med. 2020;51(1):5.

    Article  Google Scholar 

  46. Shah K, Kandre Y, Mavalankar D. Secondary attack rate in household contacts of COVID-19 Paediatric index cases: a study from Western India. Journal of Public Health (Oxford, England). 2021.

  47. Gupta N, Saravu K, Varma M, Pm A, Shetty S, Umakanth S. Transmission of SARS-CoV-2 infection by children: a study of contacts of index paediatric cases in India. Journal of tropical pediatrics. 2021;67(1):fmaa081.

    Article  PubMed  Google Scholar 

  48. Kim J, Choe YJ, Lee J, Park YJ, Park O, Han MS, Kim JH, Choi EH. Role of children in household transmission of COVID-19. Arch Dis Child. 2021;106(7):709–11.

  49. Yoon Y, Choi G-J, Kim JY, Kim K-R, Park H, Chun JK, et al. Childcare Exposure to Severe Acute Respiratory Syndrome Coronavirus 2 for 4-Year-Old Presymptomatic Child, South Korea. Emerg Infect Dis. 2021;27(2):341.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Macartney K, Quinn HE, Pillsbury AJ, Koirala A, Deng L, Winkler N, et al. Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study. Lancet Child Adolesc Health. 2020;4(11):807–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Zimmerman KO, Akinboyo IC, Brookhart MA, Boutzoukas AE, McGann K, Smith MJ, et al. Incidence and secondary transmission of SARS-CoV-2 infections in schools. Pediatrics. 2021.

  52. Gilliam WS, Malik AA, Shafiq M, Klotz M, Reyes C, Humphries JE, Murray T, Elharake JA,Wilkinson D, Omer SB. COVID-19 Transmission in US Child Care Programs. Pediatrics. 2021;147(1):e2020031971.

  53. Crawley E, Loades M, Feder G, Logan S, Redwood S, Macleod J. Wider collateral damage to children in the UK because of the social distancing measures designed to reduce the impact of COVID-19 in adults. BMJ Paediatrics Open. 2020;4(1):e000701.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Munro APS, Faust SN. Children are not COVID-19 super spreaders: time to go back to school. Arch Dis Child. 2020;105(7):618–9.

  55. Lee J. Mental health effects of school closures during COVID-19. The Lancet Child & Adolescent Health. 2020;4(6).

  56. Zhu Y, Bloxham CJ, Hulme KD, Sinclair JE, Tong ZWM, Steele LE, et al. A meta-analysis on the role of children in SARS-CoV-2 in household transmission clusters. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020:ciaa1825.

  57. Ludvigsson JF. Children are unlikely to be the main drivers of the COVID-19 pandemic - A systematic review. Acta Paediatr. 2020;109(8):1525–30.

    Article  CAS  PubMed  Google Scholar 

  58. Grijalva CG, Rolfes MA, Zhu Y, McLean HQ, Hanson KE, Belongia EA, et al. Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020. MMWR Morbidity and mortality weekly report. 2020;69(44):1631–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Jing Q-L, Liu M-J, Zhang Z-B, Fang L-Q, Yuan J, Zhang A-R, et al. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. The Lancet Infectious Diseases. 2020;20(10):1141–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Hausler M, van Helden J, Kleines M. Retarded decline of the share of SARS-CoV-2-positive children in North Rhine-Westphalia, Germany. J Med Virol.7.

  61. Bi Q, Lessler J, Eckerle I, Lauer SA, Kaiser L, Vuilleumier N, et al. Insights into household transmission of SARS-CoV-2 from a population-based serological survey. Nat Commun. 2021;12(1):3643.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Fung HF, Martinez L, Alarid-Escudero F, Salomon JA, Studdert DM, Andrews JR, et al. The Household Secondary Attack Rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Rapid Review. Clinical Infectious Diseases. 2020;73(Supplement_2):S138-S45.

    Google Scholar 

  63. Petersen MS, Kristiansen MF, Reinert HW, Fjallsbak JP, Christiansen DH, Gaini S, et al. Seroprevalence of SARS-CoV-2-Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020. Emerg Infect Dis. 2021;27(11):2795–801.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Blaisdell LL, Cohn W, Pavell JR, Rubin DS, Vergales JE. Preventing and mitigating SARS-CoV-2 transmission—four overnight camps, Maine, June–August 2020. Morbidity and Mortality Weekly Report. 2020;69(35):1216.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Szablewski CM, Chang KT, McDaniel CJ, Chu VT, Yousaf AR, Schwartz NG, Brown M, Winglee K, Paul P, Cui Z, Slayton RB, Tong S, Li Y, Uehara A, Zhang J, Sharkey SM, Kirking HL, Tate JE, Dirlikov E, Fry AM, Hall AJ, Rose DA, Villanueva J, Drenzek C, Stewart RJ, Lanzieri TM; Camp Outbreak Field Investigation Team. SARS-CoV-2 transmission dynamics in a sleep-away camp. Pediatrics. 2021;147(4):e2020046524.

  66. Torres JP, Piñera C, De La Maza V, Lagomarcino AJ, Simian D, Torres B, Urquidi C, Valenzuela MT, O'Ryan M. Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence in Blood in a Large School Community Subject to a Coronavirus Disease 2019 Outbreak: A Cross-sectional Study. Clin Infect Dis. 2021;73(2):e458–65.

  67. Park YJ, Choe YJ, Park O, Park SY, Kim Y-M, Kim J, et al. Contact tracing during coronavirus disease outbreak, South Korea, 2020. Emerg Infect Dis. 2020;26(10):2465–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

No funding for this project was received.

Author information

Authors and Affiliations

  1. Department of Pediatrics, BC Children’s Hospital, 4500 Oak Street, V6H 3N1, Vancouver, BC, Canada

    Sarah L Silverberg, Hennady P Shulha, Laura Sauvé & Manish Sadarangani

  2. Faculty of Medicine, University of British Columbia, Vancouver, Canada

    Bei Yuan Zhang, Shu Nan Jessica Li & Conrad Burgert

  3. Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, Canada

    Hennady P Shulha, Laura Sauvé & Manish Sadarangani

  4. BC Centre for Disease Control, Vancouver, Canada

    Hennady P Shulha

  5. University of British Columbia Library, Vancouver, Canada

    Vanessa Kitchin

Authors
  1. Sarah L Silverberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bei Yuan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shu Nan Jessica Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Conrad Burgert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hennady P Shulha
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vanessa Kitchin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Laura Sauvé
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Manish Sadarangani
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SS conceptualized and designed the study and data collection instruments, coordinated and supervised data collection, collected data, carried out the initial analyses, drafted and revised the manuscript. SNJL and CB collected data, designed the data collection instruments, and reviewed and revised the manuscript. VK designed the database search strategies. BYZ collected data, designed the data collection instruments, carried out the initial analysis, and reviewed and revised the manuscript. HPS designed and conducted the analysis and reviewed the manuscript. MS and LS conceptualized and designed the study and critically reviewed and revised the manuscript for important intellectual content. All authors reviewed and approved the final manuscript as submitted.

Corresponding author

Correspondence to Sarah L Silverberg.

Ethics declarations

Ethics approval and consent to participate

not applicable.

Consent for publication

not applicable.

Competing interests

MS is supported via salary awards from the BC Children’s Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research. MS has been an investigator on projects funded by GlaxoSmithKline, Merck, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines. All funds have been paid to his institute, and he has not received any personal payments. No other authors have competing interests to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silverberg, S.L., Zhang, B.Y., Li, S.N.J. et al. Child transmission of SARS-CoV-2: a systematic review and meta-analysis. BMC Pediatr 22, 172 (2022). https://doi.org/10.1186/s12887-022-03175-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12887-022-03175-8

Keywords

BMC Pediatrics

ISSN: 1471-2431

Contact us